Gemtuzumab Ozogamicin treatment represents a important development in the therapy of severe myeloid malignancy, mainly aggressive leukemic leukemia (AML). The conjugate joins a humanized molecule specific to the CD33 https://mediajx.com/story27914122/gemtuzumab-treatment-a-detailed-copyrightination